News
5d
Zacks Investment Research on MSNCRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?CRISPR Therapeutics CRSP and Intellia Therapeutics NTLA are leading developers of therapies that utilize the Nobel ...
Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...
A new PET/CT imaging technique that visualizes activated fibroblasts in the heart muscle enables early detection of multiple forms of cardiomyopathy, according to research presented at the Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results